Bell Michael Brian

Michael Brian Bell serves as the Chief Financial Officer at Guardant Health, Inc., a company focused on innovative cancer diagnostics. His recent trading activity includes multiple disclosures reported through SEC Form 4, reflecting his role in the healthcare sector. From March 13, 2026, to July 2, 2026, Bell reported 14 transactions exclusively involving sales, with amounts ranging from $668.4K to $261.1K, including a notable grant/exercise valued at approximately $668,393.78 on July 2, 2026.